trial · primary record
Danazol
Telomere Disease
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2025-10-31 |
| Primary endpoint | Number of Participants With a Reduction in Telomere Attrition Rate at 6 Months |
| Registry ID | NCT03312400 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:38.236Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03312400
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.